Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

    NIH offers five-year, milestone-driven awards to develop and validate technologies for studying senescent cell diversity and its effects on aging and disease; clinical trials are not allowed.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

    NIH supports Cellular Senescence Network centers to discover and validate cellular senescence signatures and biomarkers and study their roles in health and disease; clinical trials are not allowed.

    HHS-NIH11Due Nov 23, 2026· 2d$15,000,000

    Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)

    NIH funding supports a Stage 2 Cellular Senescence Network center to coordinate, integrate, and share data, maintain data infrastructure, and organize consortium outreach; clinical trials are not allowed.

    HHS-NIH11Due Nov 23, 2026· 2d$15,000,000

    The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

    The NCI plans to fund research projects using systems-level approaches to study metastasis within its Metastasis Research Network, with applications expected in Fall 2025.

    HHS-NIH11Due Jun 5, 2027$2,500,000

    Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

    NIH funds multisite trials and observational studies using clinical research networks for infants, children, women, pregnant and lactating women, and people with disabilities through milestone-based phases.

    HHS-NIH11Due Mar 15, 2027$6,250,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted